EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A New Selection Strategy to Enrich Dopaminergic Neurons Facilitates Comparisons Between Patient iPSC-Derived Lines

Ellen Hertz, Gani Perez, Krystyna Rytel, Martha Kirby iD, Stacie Anderson, Stephen Wincovitch, Tim Ahfeldt, Joel Blanchard, Ying Hao iD, Ziyi Li iD, Kate Andersh, Yue Andy Qi iD und 2 weitere

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27219394 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Ellen Hertz und 13 weiteren Autor:innen. Beteiligte Einrichtung: Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Dopaminergic Neurons, Parkinson Disease. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Aligning Science Across Parkinson's, National Human Genome Research Institute, Center for Alzheimer’s and Related Dementias.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Comparative studies of dopaminergic (DA) neurons differentiated from induced pluripotent stem cells (iPSCs) derived from patients discordant for parkinsonism, especially siblings, provide a valuable model to explore factors underlying Parkinson disease (PD) pathogenesis. However, such studies are complicated by the inherent heterogeneity in differentiation efficiency among iPSC lines derived from different individuals. To address this technical challenge, we devised a selection strategy to enrich DA neurons expressing tyrosine hydroxylase (TH). A neomycin resistance gene (neo) was inserted at the C-terminus of the TH gene, placing its expression under the endogenous promoter. Using iPSC-derived neurons from a healthy individual (HT711), we achieved selective enrichment of TH+ neurons through geneticin selection without compromising differentiation capacity, as demonstrated by Western blots, immunocytochemistry and flow cytometry. We then applied the method to iPSCs derived from two siblings of HT711, one with Gaucher disease (GD) alone and one with both PD and GD. Quantification of multiple DA neuron markers through whole-cell proteomics confirmed their comparable enrichment in the three lines, demonstrating that the new method can be applied to iPSC lines from different individuals to standardize DA neuron cultures. While we focus on methodological developments here, a companion analysis of the same whole-cell proteomics dataset, examining molecular features potentially associated with disease statuses, has been reported separately.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Induced Pluripotent Stem CellsDopaminergic NeuronsParkinson DiseaseHumansCell DifferentiationTyrosine 3-MonooxygenaseGaucher DiseaseCell LineGlucosylceramidaseProteomics

Stichwörter der Autor:innen

GBA1Gaucher diseaseParkinson diseasedopaminergic neuron differentiationiPSCneomycin resistance

Substanzen

Tyrosine 3-MonooxygenaseGlucosylceramidase

Autor:innen und Institutionen

  • Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  • Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA.
  • Core Facilities, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  • Nash Family Department of Neuroscience at Mount Sinai, New York, NY 10029, USA.
  • Center for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.
  • DataTecnica LLC., Washington, DC 20037, USA.

ORCID-Profile: Martha Kirby, Ying Hao, Ziyi Li, Yue Andy Qi, Yu Chen

Förderung

  • Aligning Science Across Parkinson's
  • National Human Genome Research Institute
  • Center for Alzheimer’s and Related Dementias
  • National Institute on Aging
  • National Institute of Neurological Disorders and Stroke
  • National Institutes of Health
  • Aligning Science Across Parkinson’s

Zitieren

APA

Hertz, E., Perez, G., Rytel, K., Kirby, M., Anderson, S., Wincovitch, S., Ahfeldt, T., Blanchard, J., Hao, Y., Li, Z., Andersh, K., Qi, Y. A., Sidransky, E., & Chen, Y. (2026). A New Selection Strategy to Enrich Dopaminergic Neurons Facilitates Comparisons Between Patient iPSC-Derived Lines. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27219394

Vancouver

Hertz E, Perez G, Rytel K, Kirby M, Anderson S, Wincovitch S, et al. A New Selection Strategy to Enrich Dopaminergic Neurons Facilitates Comparisons Between Patient iPSC-Derived Lines. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27219394

BibTeX
@article{Hertz2026,
  author = {Hertz, Ellen and Perez, Gani and Rytel, Krystyna and Kirby, Martha and Anderson, Stacie and Wincovitch, Stephen and Ahfeldt, Tim and Blanchard, Joel and Hao, Ying and Li, Ziyi and Andersh, Kate and Qi, Yue Andy and Sidransky, Ellen and Chen, Yu},
  title = {A New Selection Strategy to Enrich Dopaminergic Neurons Facilitates Comparisons Between Patient iPSC-Derived Lines},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27219394}
}
Kostenlos starten →